ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · IEX Real-Time Price · USD
5.08
+0.17 (3.46%)
Apr 19, 2024, 12:35 PM EDT - Market open
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $3.44 billion as of April 19, 2024. Its market cap has increased by 412.09% in one year.
Market Cap
3.44B
Enterprise Value
3.92B
1-Year Change
412.09%
Ranking
Category
Stock Price
$5.10
Market Cap Chart
Since July 28, 2015, ImmunityBio's market cap has increased from $2.67B to $3.44B, an increase of 28.93%. That is a compound annual growth rate of 2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 3.53B | 6.51% |
| Apr 16, 2024 | 3.32B | -6.11% |
| Apr 15, 2024 | 3.53B | 2.54% |
| Apr 12, 2024 | 3.44B | -15.68% |
| Apr 11, 2024 | 4.08B | 1.68% |
| Apr 10, 2024 | 4.02B | -3.24% |
| Apr 9, 2024 | 4.15B | -0.16% |
| Apr 8, 2024 | 4.16B | 8.06% |
| Apr 5, 2024 | 3.85B | 1.60% |
| Apr 4, 2024 | 3.79B | -1.58% |
| Apr 3, 2024 | 3.85B | 8.35% |
| Apr 2, 2024 | 3.55B | -0.94% |
| Apr 1, 2024 | 3.59B | -0.93% |
| Mar 28, 2024 | 3.62B | -1.65% |
| Mar 27, 2024 | 3.68B | 6.64% |
| Mar 26, 2024 | 3.45B | -5.88% |
| Mar 25, 2024 | 3.67B | -10.38% |
| Mar 22, 2024 | 4.09B | -1.62% |
| Mar 21, 2024 | 4.16B | 3.00% |
| Mar 20, 2024 | 4.04B | 10.31% |
| Mar 19, 2024 | 3.66B | 4.80% |
| Mar 18, 2024 | 3.49B | 1.95% |
| Mar 15, 2024 | 3.43B | 4.48% |
| Mar 14, 2024 | 3.28B | -3.35% |
| Mar 13, 2024 | 3.39B | 0.59% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Envista Holdings | 3.40B |
| Alvotech | 3.40B |
| Crinetics Pharmaceuticals | 3.39B |
| Prestige Consumer Healthcare | 3.38B |
| Iovance Biotherapeutics | 3.33B |
| Fortrea Holdings | 3.29B |
| Axsome Therapeutics | 3.26B |
| Progyny | 3.22B |